- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-pentamer
- Ligands
- 5 x CA: CALCIUM ION(Non-covalent)
- 40 x MC3: 1,2-DIMYRISTOYL-RAC-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
MC3.2: 2 residues within 4Å:- Chain A: Y.33
- Ligands: MC3.3
Ligand excluded by PLIPMC3.3: 9 residues within 4Å:- Chain A: L.21, L.22, C.23, W.24, R.25, Y.29, Y.33, F.282
- Ligands: MC3.2
Ligand excluded by PLIPMC3.4: 4 residues within 4Å:- Chain A: I.46, L.54, Q.58, V.253
Ligand excluded by PLIPMC3.5: 2 residues within 4Å:- Chain A: I.38
- Ligands: MC3.27
Ligand excluded by PLIPMC3.6: 4 residues within 4Å:- Chain A: Y.44, R.47, V.272, V.273
Ligand excluded by PLIPMC3.7: 3 residues within 4Å:- Chain A: L.271, V.272, V.273
Ligand excluded by PLIPMC3.8: 6 residues within 4Å:- Chain A: R.13, L.14
- Chain E: Y.33, G.34, L.37
- Ligands: MC3.42
Ligand excluded by PLIPMC3.9: 14 residues within 4Å:- Chain A: L.14, G.15, S.18, R.19, L.21, L.22, L.279
- Chain E: E.35, I.38, F.39, Y.245, L.249, L.252, F.281
Ligand excluded by PLIPMC3.11: 2 residues within 4Å:- Chain B: Y.33
- Ligands: MC3.12
Ligand excluded by PLIPMC3.12: 9 residues within 4Å:- Chain B: L.21, L.22, C.23, W.24, R.25, Y.29, Y.33, F.282
- Ligands: MC3.11
Ligand excluded by PLIPMC3.13: 4 residues within 4Å:- Chain B: I.46, L.54, Q.58, V.253
Ligand excluded by PLIPMC3.14: 2 residues within 4Å:- Chain B: I.38
- Ligands: MC3.45
Ligand excluded by PLIPMC3.15: 4 residues within 4Å:- Chain B: Y.44, R.47, V.272, V.273
Ligand excluded by PLIPMC3.16: 3 residues within 4Å:- Chain B: L.271, V.272, V.273
Ligand excluded by PLIPMC3.17: 6 residues within 4Å:- Chain B: R.13, L.14
- Chain D: Y.33, G.34, L.37
- Ligands: MC3.33
Ligand excluded by PLIPMC3.18: 14 residues within 4Å:- Chain B: L.14, G.15, S.18, R.19, L.21, L.22, L.279
- Chain D: E.35, I.38, F.39, Y.245, L.249, L.252, F.281
Ligand excluded by PLIPMC3.19: 14 residues within 4Å:- Chain A: E.35, I.38, F.39, Y.245, L.249, L.252, F.281
- Chain C: L.14, G.15, S.18, R.19, L.21, L.22, L.279
Ligand excluded by PLIPMC3.21: 2 residues within 4Å:- Chain C: Y.33
- Ligands: MC3.22
Ligand excluded by PLIPMC3.22: 9 residues within 4Å:- Chain C: L.21, L.22, C.23, W.24, R.25, Y.29, Y.33, F.282
- Ligands: MC3.21
Ligand excluded by PLIPMC3.23: 4 residues within 4Å:- Chain C: I.46, L.54, Q.58, V.253
Ligand excluded by PLIPMC3.24: 2 residues within 4Å:- Chain C: I.38
- Ligands: MC3.36
Ligand excluded by PLIPMC3.25: 4 residues within 4Å:- Chain C: Y.44, R.47, V.272, V.273
Ligand excluded by PLIPMC3.26: 3 residues within 4Å:- Chain C: L.271, V.272, V.273
Ligand excluded by PLIPMC3.27: 6 residues within 4Å:- Chain A: Y.33, G.34, L.37
- Chain C: R.13, L.14
- Ligands: MC3.5
Ligand excluded by PLIPMC3.28: 14 residues within 4Å:- Chain C: E.35, I.38, F.39, Y.245, L.249, L.252, F.281
- Chain D: L.14, G.15, S.18, R.19, L.21, L.22, L.279
Ligand excluded by PLIPMC3.30: 2 residues within 4Å:- Chain D: Y.33
- Ligands: MC3.31
Ligand excluded by PLIPMC3.31: 9 residues within 4Å:- Chain D: L.21, L.22, C.23, W.24, R.25, Y.29, Y.33, F.282
- Ligands: MC3.30
Ligand excluded by PLIPMC3.32: 4 residues within 4Å:- Chain D: I.46, L.54, Q.58, V.253
Ligand excluded by PLIPMC3.33: 2 residues within 4Å:- Chain D: I.38
- Ligands: MC3.17
Ligand excluded by PLIPMC3.34: 4 residues within 4Å:- Chain D: Y.44, R.47, V.272, V.273
Ligand excluded by PLIPMC3.35: 3 residues within 4Å:- Chain D: L.271, V.272, V.273
Ligand excluded by PLIPMC3.36: 6 residues within 4Å:- Chain C: Y.33, G.34, L.37
- Chain D: R.13, L.14
- Ligands: MC3.24
Ligand excluded by PLIPMC3.37: 14 residues within 4Å:- Chain B: E.35, I.38, F.39, Y.245, L.249, L.252, F.281
- Chain E: L.14, G.15, S.18, R.19, L.21, L.22, L.279
Ligand excluded by PLIPMC3.39: 2 residues within 4Å:- Chain E: Y.33
- Ligands: MC3.40
Ligand excluded by PLIPMC3.40: 9 residues within 4Å:- Chain E: L.21, L.22, C.23, W.24, R.25, Y.29, Y.33, F.282
- Ligands: MC3.39
Ligand excluded by PLIPMC3.41: 4 residues within 4Å:- Chain E: I.46, L.54, Q.58, V.253
Ligand excluded by PLIPMC3.42: 2 residues within 4Å:- Chain E: I.38
- Ligands: MC3.8
Ligand excluded by PLIPMC3.43: 4 residues within 4Å:- Chain E: Y.44, R.47, V.272, V.273
Ligand excluded by PLIPMC3.44: 3 residues within 4Å:- Chain E: L.271, V.272, V.273
Ligand excluded by PLIPMC3.45: 6 residues within 4Å:- Chain B: Y.33, G.34, L.37
- Chain E: R.13, L.14
- Ligands: MC3.14
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Owji, A.P. et al., Structures and gating mechanisms of human bestrophin anion channels. Nat Commun (2022)
- Release Date
- 2022-07-13
- Peptides
- Bestrophin-1: ABCDE
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
DB
BC
ED
AE
C - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-pentamer
- Ligands
- 5 x CA: CALCIUM ION(Non-covalent)
- 40 x MC3: 1,2-DIMYRISTOYL-RAC-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Owji, A.P. et al., Structures and gating mechanisms of human bestrophin anion channels. Nat Commun (2022)
- Release Date
- 2022-07-13
- Peptides
- Bestrophin-1: ABCDE
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
DB
BC
ED
AE
C - Membrane
-
We predict this structure to be a membrane protein.